Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Watchlist
Price: 2 956.3999 INR -0.03%
Market Cap: 246.3B INR
Have any thoughts about
Dr. Lal PathLabs Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
Dr. Lal PathLabs Ltd

Rotate your device to view
Cash Flow Statement
Currency: INR
Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024
Operating Cash Flow
Net Income
2 276
1 155
2 965
4 110
3 503
2 509
2 411
3 048
3 623
4 066
Depreciation & Amortization
728
374
772
795
1 081
1 431
1 502
1 465
1 436
1 426
Other Non-Cash Items
648
366
895
1 299
1 350
1 301
1 357
1 367
1 257
1 296
Cash Taxes Paid
935
382
1 017
1 221
1 300
1 259
1 064
1 084
1 320
1 438
Cash Interest Paid
1
0
158
319
304
337
377
341
294
255
Change in Working Capital
(813)
3 093
(650)
(877)
(1 467)
(1 357)
(710)
(682)
(963)
(1 423)
Cash from Operating Activities
2 839
N/A
2 821
-1%
3 982
+41%
5 327
+34%
4 467
-16%
3 884
-13%
4 560
+17%
5 198
+14%
5 353
+3%
5 365
+0%
Investing Cash Flow
Capital Expenditures
(796)
(222)
(596)
(718)
(4 761)
(4 708)
(446)
(432)
(574)
(453)
Other Items
535
(1 422)
(1 524)
(644)
269
(1 592)
(2 427)
(1 283)
332
(1 645)
Cash from Investing Activities
(261)
N/A
(1 188)
-355%
(2 120)
-78%
(1 362)
+36%
(4 493)
-230%
(6 301)
-40%
(2 873)
+54%
(1 715)
+40%
(243)
+86%
(2 099)
-765%
Financing Cash Flow
Net Issuance of Common Stock
2
2
3
2
1
3
9
24
35
74
Net Issuance of Debt
(351)
(192)
(235)
(103)
2 834
1 637
(1 432)
(1 460)
(1 868)
(1 166)
Cash Paid for Dividends
(1 555)
0
(995)
(2 162)
(1 167)
(1 030)
(1 030)
(1 013)
(2 012)
(2 052)
Other
(1)
(1 904)
(159)
(320)
(304)
(337)
(379)
(343)
(294)
(255)
Cash from Financing Activities
(1 905)
N/A
(1 577)
+17%
(1 386)
+12%
(2 583)
-86%
1 365
N/A
274
-80%
(2 832)
N/A
(2 792)
+1%
(4 139)
-48%
(3 399)
+18%
Change in Cash
Net Change in Cash
673
N/A
56
-92%
476
+745%
1 382
+190%
1 339
-3%
(2 143)
N/A
(1 145)
+47%
691
N/A
972
+41%
(132)
N/A
Free Cash Flow
Free Cash Flow
2 043
N/A
2 599
+27%
3 386
+30%
4 609
+36%
(295)
N/A
(825)
-180%
4 115
N/A
4 767
+16%
4 779
+0%
4 912
+3%

See Also

Discover More